Trigeminal Neuralgia. Trigeminal neuralgia
Conditions
Interventions
Intervention 1: First group: Ten patients who assigned randomly in this group take Pregabaline seventy-five milligrams two times daily for thirty days. After five days interval without any drug these
Treatment - Drugs
First group: Ten patients who assigned randomly in this group take Pregabaline seventy-five milligrams two times daily for thirty days. After five days interval without any drug these patients take Ca
First group: Ten patients who assigned randomly in this group take Carbamazepine two hundred milligrams two times daily for thirty days. After five days interval without any drug these patients take P
Sponsors
Shahed University
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Age between eighteen to seventy-five years old. Suffering from Idiopathic Trigeminal neuralgia according to International Headache Society criteria.
Exclusion criteria
Exclusion criteria: Suffering from other kinds of head and facial pain History of psychiatric diseases, Renal failure, liver failure, Heart failure, Thrombocytopenia, Leuckopenia, Anemia and malignancy Pregnancy and Breast feeding
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuralgic pain intensity. Timepoint: Before starting the drugs and from days twenty- eight to thirtieth in each period. Method of measurement: Visual Analogue scale (VAS).;Neuralgic pain intensity. Timepoint: Before starting the drugs and from days twenty- eight to thirtieth in each period. Method of measurement: 5 points verbal rating scale.;Duration of neuralgic pain. Timepoint: Before starting the drugs and from days twenty- eight to thirtieth in each period. Method of measurement: Average duration of attacks in seconds.;Frequency of neuralgic pain. Timepoint: Before starting the drugs and from days twenty- eight to thirtieth in each period. Method of measurement: Number of attacks in one day. | — |
Secondary
| Measure | Time frame |
|---|---|
| Unpredictable drug reactions (Pruritus, Burning sensation, Skin redness). Timepoint: immediately after patient alarm. Method of measurement: Observation, Examination, and refer to the specialist.;Drowsiness. Timepoint: Immediately after patient alarm. Method of measurement: Observation, examination, and refer to the specialist. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSiamak Afshinmajd
Shahed University
Outcome results
None listed